Emerging Strategies in Cancer Metabolism: Role of Gut Microbiota, Reactive Oxygen Species, and Short Chain Fatty Acids offers a revolutionary investigation of the complicated relationships between cancer metabolism and three crucial factors: the gut microbiota, reactive oxygen species (ROS), and the dysregulation of the short chain fatty acid (SCF) complex. This book adopts a thorough and interdisciplinary approach to untangle the intricate interactions between these components, providing fresh perspectives that fundamentally alters the understanding of cancer biology and therapy. In 14 chapters.
Emerging Strategies in Cancer Metabolism: Role of Gut Microbiota, Reactive Oxygen Species, and Short Chain Fatty Acids provides a thorough investigation of the metabolic changes that occur inside cancer cells, illuminating how these changes promote tumour survival and progression, from introduction to future aspects. Researchers in cancer research, and gut microbiology will find this an essential reference.
1. Chapter 1 Introduction to gut microbiota in cancer metabolism - p. 1 2. Chapter 2 Cancer metabolic rewiring of reactive oxygen species - p. 25 3. Chapter 3 Emerging strategies in cancer metabolism: Role of gut microbiota, reactive oxygen species, short-chain fatty acids - p. 47 4. Chapter 4 Exploring the link between gut microbiome and cancer: Metabolic implications and therapeutic avenue - p. 69 5. Chapter 5 Oxidative stress and cancer metabolism: From pathogenesis to therapeutic opportunities - p. 101 6. Chapter 6 Targeting reactive oxygen species signaling pathways for cancer metabolic reprogramming - p. 139 7. Chapter 7 SCF complex: Master regulator of metabolic adaptations in cancer cells - p. 185 8. Chapter 8 Manipulating gut microbial metabolites for cancer therapy: A metabolism-centric approach - p. 203 9. Chapter 9 Metabolic crossroads: Integrating ROS, SCF, and gut microbiota in cancer - p. 233 10. Chapter 10 Therapeutic advances: Modulating gut microbiota, ROS, and SCF pathways in cancer treatment - p. 271 11. Chapter 11 Precision medicine in cancer metabolism: Personalized approaches exploiting metabolic vulnerabilities - p. 293 12. Chapter 12 Novel biomarkers and therapeutic targets: Harnessing metabolic insights for improved cancer management - p. 313 13. Chapter 13 Future aspects: Novel strategies in cancer metabolism research and clinical interventions - p. 339 14. Chapter 14 Emerging strategies in cancer metabolism: Role of gut microbiota, reactive oxygen species, short-chain fatty acids - p. 365 15. Chapter 15 Implementing gut microbiota, ROS, and SCF modulation in cancer care: Research into practice - p. 393 16. Index - p. 423
Emerging Strategies in Cancer Metabolism: Role of Gut Microbiota, Reactive Oxygen Species, and Short Chain Fatty Acids offers a revolutionary investigation of the complicated relationships between cancer metabolism and three crucial factors: the gut microbiota, reactive oxygen species (ROS), and the dysregulation of the short chain fatty acid (SCF) complex. This book adopts a thorough and interdisciplinary approach to untangle the intricate interactions between these components, providing fresh perspectives that fundamentally alters the understanding of cancer biology and therapy. In 14 chapters.
Emerging Strategies in Cancer Metabolism: Role of Gut Microbiota, Reactive Oxygen Species, and Short Chain Fatty Acids provides a thorough investigation of the metabolic changes that occur inside cancer cells, illuminating how these changes promote tumour survival and progression, from introduction to future aspects. Researchers in cancer research, and gut microbiology will find this an essential reference.
1. Chapter 1 Introduction to gut microbiota in cancer metabolism - p. 1 2. Chapter 2 Cancer metabolic rewiring of reactive oxygen species - p. 25 3. Chapter 3 Emerging strategies in cancer metabolism: Role of gut microbiota, reactive oxygen species, short-chain fatty acids - p. 47 4. Chapter 4 Exploring the link between gut microbiome and cancer: Metabolic implications and therapeutic avenue - p. 69 5. Chapter 5 Oxidative stress and cancer metabolism: From pathogenesis to therapeutic opportunities - p. 101 6. Chapter 6 Targeting reactive oxygen species signaling pathways for cancer metabolic reprogramming - p. 139 7. Chapter 7 SCF complex: Master regulator of metabolic adaptations in cancer cells - p. 185 8. Chapter 8 Manipulating gut microbial metabolites for cancer therapy: A metabolism-centric approach - p. 203 9. Chapter 9 Metabolic crossroads: Integrating ROS, SCF, and gut microbiota in cancer - p. 233 10. Chapter 10 Therapeutic advances: Modulating gut microbiota, ROS, and SCF pathways in cancer treatment - p. 271 11. Chapter 11 Precision medicine in cancer metabolism: Personalized approaches exploiting metabolic vulnerabilities - p. 293 12. Chapter 12 Novel biomarkers and therapeutic targets: Harnessing metabolic insights for improved cancer management - p. 313 13. Chapter 13 Future aspects: Novel strategies in cancer metabolism research and clinical interventions - p. 339 14. Chapter 14 Emerging strategies in cancer metabolism: Role of gut microbiota, reactive oxygen species, short-chain fatty acids - p. 365 15. Chapter 15 Implementing gut microbiota, ROS, and SCF modulation in cancer care: Research into practice - p. 393 16. Index - p. 423
